Perceptive Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$2.16M Hold
2020
Q3
$3.19M Hold
2020
Q2
$4M Buy
2018
Q3
Sell
2018
Q2
$585K Buy